Suman Kambhampati, MD, is board-certified in Hematology/Medical Oncology. He is Co-Medical Director of the Blood Cancer Program at Sarah Cannon Cancer Institute, HCA Midwest Health located at Research Medical Center, Kansas City. Dr. Kambhampati treats patients affected by blood cancers and complex hematology issues. He has led or participated in multiple cancer research studies and published numerous professional papers. Dr. Kambhampati currently serves as Vice-Chair of the Sarah Cannon Blood Cancer Network (SCBCN) Quality Management Committee on Complex Blood Cancers and is involved with teaching and training of trainees at the Kansas City VA Medical Center, where he serves as a staff physician. He is Principal Investigator with the Southwest Oncology Group (SWOG), an affiliate of the National Cancer Institute (NCI), and leads efforts at VA to enroll patients into SWOG/NCI-sponsored clinical trials. Dr. Kambhampati has received multiple awards for both his research and patient care, including the prestigious Alpha Omega Alpha and Lauri Stauss Leukemia Foundation Research Fellow; Department of Veterans Affairs Special Contribution Awards in Clinical Practice, Research and System Redesigns; Kansas NIH COBRE First Award in Cancer Experimental Therapeutics; Kansas City Super Docs in Hematology and Oncology; Appreciation of Exceptional Leadership and Dedication to Oncology from the Association of VA Hematology and Oncology. He is a professional member of the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), the American Association for Cancer Research (AACR), and the Association of Veteran Affairs Hematology & Oncology (AVAHO), of which he served as president. He serves as board member of the Leukemia and Lymphoma Society (LLS).